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Healing duality
Using a conditional knockout mouse model that recapitulates 
the major characteristics of the skin fragility disorder reces-
sive dystrophic epidermolysis bullosa (RDEB) to explore the 
role of collagen VII (COL7A1) in wound healing, Nyström and 
colleagues demonstrated dual functions for this protein at the 
dermal–epidermal junction zone. COL7A1 is critical for main-
taining skin integrity as well as for skin wound closure. In these 
mice, loss of COL7A1 resulted in delayed reepithelialization by 
epidermal keratinocytes and altered dermal fibroblast–induced 
granulation tissue maturation. Specifically, loss of COL7A1 
altered laminin-332 organization during wound healing, leading 
to altered laminin-332/integrin α6β4 signaling required for 
keratinocyte migration. COL7A1 also promoted dermal fibro-
blast migration and cytokine production. Validation of these 
results in human RDEB wounds implicated COL7A1 as an 
important modulator of healing of chronic wounds. (J Clin Invest 
123:3498–509, 2013) Selected by J. Uitto
Immunosuppression challenges
Renal transplant recipients have a much higher risk of cancer, 
especially cutaneous squamous cell carcinomas (SCCs), and 
this increase is linked to continual immunosuppression treat-
ment following transplantation. Because risk is especially high 
following development of one SCC, studies evaluated the effects 
of the mTOR inhibitor sirolimus, a newer immunosuppres-
sor without neoplastic effects, on the recurrence rate of SCCs in 
kidney-transplant patients. Euvrard and colleagues reported that 
switching from calcineurin inhibitors (tacrolimus) to sirolimus 
exerted an antitumor effect, increasing the cancer-free survival 
of these patients after two years. In a subsequent study of kidney 
transplant patients, however, Hoogendijk and colleagues found 
that, although sirolimus was effective (50% risk reduction) in 
the first year of treatment, there was no significant difference in 
invasive SCC-free survival after two years. The first study exam-
ined a higher percentage of patients with only one prior SCC and 
compared sirolimus with tacrolimus; the second study followed 
more patients with multiple prior SCCs and compared sirolimus 
treatment with treatment with calcineurin inhibitors or other 
immuno suppressive drugs. The authors concluded that sirolimus 
may have potential as an early immunosuppressive strategy to 
reduce the risk of cutaneous SCCs in renal transplant recipients 
with only one prior SCC. (N Engl J Med 367:329–39, 2012; J Clin 
Oncol 31:1317–23, 2013) Selected by J. Bavinck
Live long and prosper
The naked mole rat has an exceptionally long life span consider-
ing its small body mass. Interestingly, naked mole rats are particu-
larly resistant to cancer. A recent study of cells from these animals 
by Tian and colleagues revealed the presence of secreted 
extremely high–molecular-mass hyaluronan (HMM-HA) in 
culture medium. This extracellular matrix component represses 
mitogenic signaling and exerts anti-inflammatory effects. HMM-
HA also accumulates in tissues of naked mole rats because of 
the more robust synthesis and slower degradation of this disac-
charide polymer. In xenograft experiments, knockdown of HA 
synthase or overexpression of an HA-degrading enzyme resulted 
in malignant transformation and tumor formation, indicating 
that HMM-HA is a key factor involved in cancer resistance of 
the naked mole rat. These exciting findings offer new targets for 
development of cancer prevention and life extension strategies. 
(Nature 499:346–9, 2013) Selected by D. Fisher
Follicle regeneration
Rodents are capable of regenerating hair follicles during 
wound healing; however, cutaneous wounds in adult humans 
heal via fibrotic repair and lack hair follicle regeneration. Gay 
and colleagues recently determined that dermal γδ T cells 
induce hair follicle neogenesis after wounding. These cells 
secrete fibroblast growth factor 9 (Fgf9), which is upregulated 
in wound dermis before new follicle placodes are detected, 
and this factor is an important contributor to hair follicle 
regeneration. Fgf9 promotes dermal fibroblast Wnt expression 
and activation, which is a first step in hair follicle neogenesis. 
In addition, exogenous Fgf9 induced Wnt activity in wounds, 
generating a positive feedback loop of expression and activa-
tion, and positively influenced wound-induced hair follicle 
neogenesis. In additional studies, these investigators found 
that human dermis lacked sufficient resident γδ T cells com-
pared with mouse dermis, perhaps explaining the poor regen-
erative capability of human skin following wounding. (Nat 
Med 19:916–23, 2013) Selected by M. Amagai
Innate immune woes
Atopic dermatitis (AD), which is characterized by eosinophil and 
mast cell accumulation in lesional skin, has been associated with 
polymorphism of ST2, a T helper type 2 cell receptor that binds 
IL-33. In addition, IL-33 is upregulated in the epidermis of lesional 
skin of AD patients. These findings spurred Imai and colleagues 
to generate a transgenic mouse with skin-specific overexpression 
of IL-33. These animals developed spontaneous itchy dermatitis, 
due to the infiltration of eosinophils, and exhibited increased 
numbers of group 2 innate lymphoid cells (ILC2s), which serve 
as innate immune-cell activators. Thus, skin-specific IL-33 
expression causes AD-like cutaneous manifestations complete 
with abundant eosinophils, which migrate as a result of the 
production of IL-5 and IL-13 by activated ILC2s. Because this 
process is important in allergic inflammation pathogenesis, use 
of these mice will allow further exploration into IL-33 biology 
and offer opportunities to explore targeting of the innate immune 
system for treatment of allergic inflammation. (Proc Natl Acad Sci 
USA 110:13921–6, 2013) Selected by L. BeckJournal of Investigative Dermatology (2013) 133, 2502. doi:10.1038/jid.2013.386
